deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT05552352

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease (VRAP-Heart)

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease - A Randomized-Controlled Multicenter Study

Sponsor: Edwards Lifesciences

Updated 6 times since 2022 Last updated: Aug 22, 2025 Started: Oct 5, 2022 Primary completion: Aug 31, 2026 Completion: Feb 28, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Severe Aortic Valve Stenosis and is currently actively recruiting participants. Edwards Lifesciences leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshotNot Yet Recruiting~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – ~Sep 2025 · 8 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting NA

    Status: UnknownRecruiting

  2. Jan 2025 — Sep 2025 [monthly]

    Unknown NA

    Status: RecruitingUnknown

  3. Sep 2024 — Jan 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Jan 2023 — Jul 2024 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

Show 1 earlier version
  1. Sep 2022 — Jan 2023 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Edwards Lifesciences
  • Heinrich-Heine University, Duesseldorf
Data source: Heinrich-Heine University, Duesseldorf

For direct contact, visit the study record on ClinicalTrials.gov .